MiR-150, which also showed downregulated expression in patients with ASO, has been reported to negatively regulate the function of CD4+ T cells through the AKT3/Bim signaling pathway in acute graft-versus-host disease [37]. The gene discussed is BCL2L11; the disease is acute graft versus host disease.